Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin

Details for Australian Patent Application No. 2009222515 (hide)

Owner Novartis AG

Inventors Burkey, Bryan; Hughes, Thomas Edward

Agent Davies Collison Cave

Pub. Number AU-A-2009222515

Parent 2005299808

Filing date 1 October 2009

Wipo publication date 22 October 2009

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

22 October 2009 Application Open to Public Inspection

  Published as AU-A-2009222515

22 October 2009 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009222516-Microwave system calibration apparatus and method of use

2009222514-Wiping Excess Coating From Hot Dip Metal Coated Wires